Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open, Non-Interventional, Multicenter Trial of MabThera in Combination With CHOP (or CHOP-like) Chemotherapy in Patients With Aggressive B-Cell Lymphoma

NCT02486952 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT02486952
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02486952 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open, Non-Interventional, Multicenter Trial of MabThera in Combination With CHOP (or CHOP-like) Chemotherapy in Patients With Aggressive B-Cell Lymphoma
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Completed
Start date
August 31, 2005
Completion date
January 31, 2011
Enrollment
154 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma, lymphoma, large b-cell, diffuse, non-hodgkin's lymphoma, lymphoma, non hodgkin, relapsed or refractory diffuse large b-cell lymphoma